Bioadaptives, Inc. (BDPT) Non Operating Investment Income (2013 - 2023)

Bioadaptives has reported Non Operating Investment Income for 9 years, with the latest figure at -$11.0 in Q4 2023.

• Quarterly Non Operating Investment Income fell 210.0% year-over-year to -$11.0 in Q4 2023, while the trailing twelve-month figure through Sep 2024 was -$11.0 (up 47.62% YoY) and the FY2023 annual result came in at -$42.0, up 71.62% from the prior year.
• Non Operating Investment Income steadied at -$11.0 in Q4 2023 per BDPT's latest filing, from -$11.0 in the prior quarter.
• Over five years, Non Operating Investment Income peaked at $5901.0 in Q4 2019 and troughed at -$2517.0 in Q2 2021.
• A 5-year average of $122.15 and a median of -$26.0 in 2022 frame the typical range for Non Operating Investment Income.
• The widest YoY moves for Non Operating Investment Income: up 887.22% in 2021, down 621.2% in 2021.
• Over 5 years, Non Operating Investment Income stood at $5901.0 in 2019, then tumbled by 99.1% to $53.0 in 2020, then tumbled by 379.25% to -$148.0 in 2021, then surged by 106.76% to $10.0 in 2022, then tumbled by 210.0% to -$11.0 in 2023.
• According to Business Quant data, Non Operating Investment Income over the past three periods registered -$11.0, -$11.0, and -$10.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.